OUR "R3" EXCLUSIVE REPORT:
What is Industrial Hemp: The "Hidden" Truth About Legal CBD Oil & the NEW Gold Rush?
DID YOU KNOW THAT CBD OIL HELPS TO HEAL ACID REFLUX?
DID YOU KNOW THAT CBD OIL ALSO HELPS TO RESOLVE PTSD?
CBD Oil Market Estimated to Grow to
$2.1B by 2020, Report Finds
A recent report by Forbes.com highlights the tremendous growth expceted in the cannabidiol (CBD) market over the next three years. The report also explains that hemp-derived CBD will account for $450 million of the estimated total sales of $2.1B by 2020.
As quoted within the report, the cannabidiol (CBD) market is estimated to grow by 700% by 2020, according to Forbes. A new report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020, an astronomical jump in value compared to last year’s CBD market of $202 million.
CBD is one of the more than 85 cannabinoids so far identified in marijuana and hemp. Unlike the better-known compound tetrahydrocannabinol (THC), CBD is not psychoactive, meaning it won’t cause a high. Thousands of studies have shown that CBD possesses an array of therapeutic benefits, including antioxidant and neuroprotective properties. “In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now there are 15 states that allow CBD only — this is in addition to the 28 states plus DC that have legalized medical marijuana,” Matt Karnes of Greenwave Advisors told Forbes, believing the growing CBD market will exceed the estimations by Hemp Business Journal. The Hemp Business Journal report estimates that $450 million of the projected $2.1 billion in sales by 2020 will come from hemp-based sources. The hemp-derived CBD market was $90 million in 2015.
CBD that is derived from hemp is legal to import and purchase in all 50 U.S. states, without a prescription. Cannabidiol itself isn’t listed in the Controlled Substances Act like THC and marijuana.
Current market leader Medical Marijuana, Inc. told Forbes that it pulls in over $800,000 in retail hemp-based CBD sales per month. The company’s sales are expected to be $9 million in 2016, up from $3.4 million in 2013.
Being the only CBD company on the market at the time, Medical Marijuana, Inc. reached $14.5 million in sales in 2014, and while their customer count has increased since then, an increase in competition and a drop in prices has affected sales figures. Its investment company, Axim Biotechnologies, holds a patent and license for a CBD chewing gum called CanChew.
Venture capital firm General Hemp, which has controlling interest in Medical Marijuana, Inc., made $34 million in CBD sales between 2014 and 2016, not including Medical Marijuana, Inc. companies.
With the recent influx in competition and a lack of regulation, consumers must educate themselves to ensure they buy high-quality CBD. Medical Marijuana, Inc. says that the CBD oil used in its Real Scientific Hemp Oil and Dixie Botanicals products is derived from hemp grown in Austria and that it’s tested several times for purity and cannabinoid content.
According to Forbes, data from Headset Research says that it’s difficult for consumers to know what they’re getting when they purchase CBD products. The information offered on most product labels is limited.
“Many order large vats of CBD oil that is produced from Chinese industrial hemp and cut that into their products. This makes it difficult for those who grow and extract CBD locally to compete and consumers aren’t currently educated enough to have a preference for ‘homegrown’ CBD products.”
The best play for consumers is “to do their homework,” Forbes suggests, by looking into where a company acquires its CBD. Finding out which products are best will likely include trial and error, the publication says.
SOURCE: (Cannibus Investing News)
Industrial Hemp-Derived CBD: What's There to Know?
As CBD’s medicinal qualities continue to make waves across the country, more states are starting to look into limited medical marijuana legalization laws so their residents can get access to CBD products to treat their debilitating medical conditions. If a patient is unlucky enough to live in a state with no laws in place or no legal access to CBD products, he or she may feel as if there’s no viable alternative that can provide the same relief.
Here’s where hemp-derived CBD products come in. There’s been much debate suggesting that CBD derived from industrial hemp has the same properties as cannabis-derived CBD, making it a potential alternative for patients who can’t legally access medical marijuana but can legally acquire hemp-derived CBD products. A lot of people aren’t entirely familiar with hemp-derived CBD, however. What exactly is there to know?
Some Facts About Industrial Hemp-Derived CBD
Here are a few facts about CBD derived from industrial hemp:
Agricultural hemp and medical marijuana both come from the Cannabis Sativa L. plant.
Agricultural hemp, which is often referred to as “hemp stalk,” grows differently than THC-containing cannabis, and looks similar to bamboo.
THC-producing marijuana plants are grown to an average of five feet in height, spaced six to eight feet apart. Agricultural hemp is grown to a height of 10 to 15 feet or more before harvest, placed three to six inches apart.
Hemp has little potential to produce high-content THC when pollinated.
As long as agricultural hemp plants are pollinated by members of their own crop, the genetics will remain similar with low levels of THC.
There is a strong legal argument that production and distribution of CBD oils/products derived from imported raw material industrial hemp is not a violation of the Controlled Substances Act (CSA); in fact, one Colorado law firm has published a written opinion making the case.
CBD Oil & the Endocannabinoid Connection
The endogenous cannabinoid system, named after the plant that led to its discovery, is perhaps the most important physiologic system involved in establishing and maintaining human health. Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells. In each tissue, the cannabinoid system performs different tasks, but the goal is always the same: homeostasis, the maintenance of a stable internal environment despite fluctuations in the external environment. Cannabinoids promote homeostasis at every level of biological life, from the sub-cellular, to the organism, and perhaps to the community and beyond.
Endocannabinoids and cannabinoids are also found at the intersection of the body's various systems, allowing communication and coordination between different cell types. At the site of an injury, for example, cannabinoids can be found decreasing the release of activators and sensitizers from the injured tissue, stabilizing the nerve cell to prevent excessive firing, and calming nearby immune cells to prevent release of pro-inflammatory substances. Three different mechanisms of action on three different cell types for a single purpose: minimize the pain and damage caused by the injury.
The endocannabinoid system, with its complex actions in our immune system, nervous system, and all of the body's organs, is literally a bridge between body and mind. By understanding this system we begin to see a mechanism that explains how states of consciousness can promote health or disease.
The Endocannabinoid System: What Nurses Need to Know, An Introduction (Article written by NurseManifest: A Call to Conscience & Action)
As nurses we have a lot to learn about cannabis, including how it works in the mind-body-spirit system, and how we can best advocate for and support patients who could or do benefit from this medicine. Last spring, I witnessed a brief presentation being given to nurses around medical cannabis use, and it was obvious from the questions asked by many of the nurses that the social stigma around “marijuana” was alive and well. Would these nurses be so reluctant to accept and support medical cannabis use if they truly understood the endocannabinoid system (ECS)?
The ECS was discovered some time ago, with Dr. Ralph Mechoulam (Faukner, 2015) being a pioneer in this area in the mid-1990’s. There are 20,000+ scientific articles written about the endocannabinoid system (ECS). Though it has been many years since the discovery of this body regulatory system, most nurses likely know very little, if anything, about the ECS.
A functioning ECS is essential to our health and well being.
Endocannabinoids and their receptors are found throughout the body; in the brain, organs (pancreas and liver), connective tissue, bones, adipose tissues, nervous system, and immune system. We share this system in common with all other vertebrate animals, and some invertebrate animals (Sulak, 2015). Cannabinoids support homeostasis within the body’s system; the ECS is a central regulatory system, cannabinoid receptors are found throughout the body, and they are believed to be the largest receptor system in our bodies. Cell membrane cannabinoid receptors send information backwards, from the post-synaptic to the pre- synaptic nerve. CB1 (found primarily in the brain) and CB2 (mostly in the immune system and in the bones) are the main ECS receptors (Former, 2015), though several more are currently being studied. The exogenous phytocannabinoid THC, or the psychoactive compound in cannabis, works primarily on CB1 receptors (hence the “high feeling” in the brain), while the cannabinoid CBD works primarily with the immune system and creating homeostasis around the inflammatory response through CB2 receptors and does not have psychoactive effects. Other cannabinoids and their actions are still being studied, such as the non-psychoactive cannabinoids CBN and CBG, also found in cannabis. Our bodies react to both our own production of endogenous cannabinoids and to the ingestion of phyto-cannabinoids found in the cannabis plant, and other non-pyschoactive plants such as Echinacea. To read more about the science behind the ECS and endocannabinoid receptors, the following are excellent resources:
Endocannabinoids are the chemicals our own bodies make to naturally stimulate the cannabinoid receptors; anandamide and 2-arachidonoylglycerol (2-AG) are two well known endocannabinoids (Sulak, 2015) that are produced by the body as needed, though not stored int he body. The body produces these endocannabinoids in a similar fashion to how it produces endorphins (Pfrommer, 2015), and activities such as exercise support the endogenous production of cannabinoids. Endocannabinoids are also found in breast milk and in our skin. Alcohol interferes with endogenous cannabinoid production.
In general, we think of the cannabis plant as the generator of exogenous cannabinoids that we can ingest in a variety of ways, namely psychoactive THC (works with the CB1 receptors in the brain- and also in the gut) and non-psychoactive CBD (works with the CB2 receptors in the immune system and the gut). Other plants such as Echinacea also produce non-psychoactive cannabinoids and work with the ECS to support health and well being through homeostasis (Sulak, 2015).
Cannabinoid Deficiency Syndrome:
It should be clear that everybody makes cannabinoids and everybody needs cannabinoids to function. People who do not make enough cannabinoids need to supplement with exogenous cannabinoids through cannabis ingestion, in much the same way that an diabetic needs insulin supplementation. Dr. Ethan Russel’s (2004) publication on Clinical Endocannbinoid Deficiency explains this particularly well: http://www.nel.edu/pdf_/25_12/NEL251204R02_Russo_.pdf
Cancer: “Cannabinoids promote homeostasis at every level of biological life, from the sub-cellular, to the organism, and perhaps to the community and beyond. Here’s one example: autophagy, a process in which a cell sequesters part of its contents to be self-digested and recycled, is mediated by the cannabinoid system. While this process keeps normal cells alive, allowing them to maintain a balance between the synthesis, degradation, and subsequent recycling of cellular products, it has a deadly effect on malignant tumor cells, causing them to consume themselves in a programmed cellular suicide. The death of cancer cells, of course, promotes homeostasis and survival at the level of the entire organism” (Sulak, 2015, paragraph #7). Cannabinoids support apoptosis and suppress cancer tumor angiogenesis (McPartland, 2008).
Heart Disease: Additionally, it has been stated that the ECS plays an important function in protecting the heart from myocardial infarction and cannabinoids can have anti-hypertensive effects (Lamontagne et al, 2006).
Inflammation: When inflammation occurs, the ECS helps to stop the process, similar to applying the brakes on a car. This is why cannabis is proving to be good medicine for inflammatory related illness. “Activation of CB2 suppresses proinflammatory cytokines such as IL-1β and TNF-α while increasing anti-inflammatory cytokines such as IL-4 and IL-10. Although THC has well-known anti-inflammatory properties, cannabidiol also provides clinical improvement in arthritis via a cannabinoid receptor–independent mechanism” (McPartland, 2008).
PTSD: “This review shows that recent studies provided supporting evidence that PTSD patients may be able to cope with their symptoms by using cannabis products. Cannabis may dampen the strength or emotional impact of traumatic memories through synergistic mechanisms that might make it easier for people with PTSD to rest or sleep and to feel less anxious and less involved with flashback memories. The presence of endocannabinoid signalling systems within stress-sensitive nuclei of the hypothalamus, as well as upstream limbic structures (amygdala), point to the significance of this system for the regulation of neuroendocrine and behavioural responses to stress. Evidence is increasingly accumulating that cannabinoids might play a role in fear extinction and antidepressive effects. It is concluded that further studies are warranted in order to evaluate the therapeutic potential of cannabinoids in PTSD.” (Passie et al, 2012).
Seizures: Most hopeful, cannabis has been used to support pediatric treatment-resistant epilepsy, and while more research needs to be done in this area, many parents are becoming medical marijuana refugees by moving to states where they can procure cannabis for their children who suffer from seizures.
Co-agonists: Cannabis increases the pain relieving effects of morphine, as discovered by researchers at UCSF. The two medications are synergistic, and this provides great hope for patients suffering intractable pain at end of life, chronic pain suffers, and opiate addicts.
Gastro-Esophageal Disorder (GERD): Research suggests that cannabis is effective in treating the symptoms of these GI disorders in part because it interacts with the endogenous cannabinoid receptors in the digestive tract, which can result in calming spasms, assuaging pain, and improving motility. Cannabis has also been shown to have anti-inflammatory properties and recent research shows crucial neuromodulatory roles in controlling the operation of the gastrointestinal system, with synthetic and natural cannabinoids acting powerfully to control gastrointestinal motility and inflammation. Cannabinoid receptors comprise G-protein coupled receptors that are predominantly in enteric and central neurones (CB1R) and immune cells (CB2R). The digestive tract contains endogenous cannabinoids (anandamide and 2-arachidonylglycerol) and cannabinoid CB1 receptors can be found on myenteric and sub mucosal nerves. Activating cannabinoid receptors has been demonstrated to inhibit gastrointestinal fluid secretion and inflammation in animal models. In the last decade, evidence obtained from the use of selective agonists and inverse agonists/antagonists indicates that manipulation of CB1R can have significant results. Research has also shown that in the case of intestinal inflammation, the body will increase the number of cannabinoid receptors in the area in an attempt to regulate the inflammation by processing more cannabinoids.
Additional Information on GERD: According to the Journal of Expert Review of Gastroenterology & Hepatology within their article, The Role of Cannabinoid Receptors in the Control of Gastrointestinal Motility and Perception, the identification of endocannabinoids and cannabinoid CB1 receptors in key areas of the intestinal wall, such as cholinergic neurons, supports a role for cannabinoids in the control of gastrointestinal motility. Activation of CB1 receptors inhibits the peristaltic reflex and slows down gastrointestinal and colonic transit. Endocannabinoids play an important inhibitory role in the control of the occurrence of transient lower esophageal sphincter relaxations. Cannabinoid receptor agonists inhibit gastric emptying and intestinal motility in humans. There is strong anatomical support for a role of CB1 receptors in the control of gastrointestinal perception, since these receptors have been identified in key sites of the neuronal circuitry involved in the transmission of visceral pain. Experimental data indicate a visceral antinociceptive action of cannabinoid receptor agonists, which remains to be confirmed in humans.
So As Nurses, What Do We Need to Know?
Legal Issues: If you live or work in a state that has legalized medical or recreational use of cannabis, familiarize yourself with the laws in that state, as well as your own workplace policies around supporting patient’s use of medical cannabis. Patients may have questions and as a patient advocate, your responsibility is to support patients with their knowledge and use of this medicine within the confines of your practice setting and state laws. You should also be aware of constraints around your role as a nurse in supporting patient use of medical cannabis. For instance, Kaiser patients in some states are likely to be removed from chronic pain patient programs if they test positive for cannabis. Nurses with knowledge around the benefits of medical cannabis can also advocate to support shifts in such policies will no longer align with the emerging ECS science.
Safety: This goes along with the legal aspects; medical cannabis patients should be supported in how to manage and store their medications with safety. While cannabis is known to be extremely safe (far safer than opiates and alcohol), cannabis consumers still need to store medication out of reach of children and pets. They should be supported in knowing the safety of driving or operating machinery if they consumer THC- based cannabis medicines. They also may need information on cannabis testing for both THC: CBD ratios, pesticides and/or other hazardous materials. Many patients need assistance with the basics around medical cannabis use, such as dosage, ratios of THC: CBD, strain information, and ingestion methods.
Overcoming Stigma: Unfortunately, a stigma was created around around cannabis during the process of prohibition in the 1930’s, which was largely financially and racially driven. Contradictory state and federal laws, and the stigma around smoking cannabis (though many cannabis patients can now get relief from vaporizing using the best vape pen for oil, drinkable tinctures, topicals, wearable patches, and edibles), along with a clear ignorance around the body’s ECS, serve to further the stigma associated with medical cannabis. Educate yourself on the roots of the prohibition of the medicine:
American Cannabis Nurses Association:
There are many nurses actively involved in supporting the use of medical cannabis and the defining the nurse’s role in this process. The ACNA has a mission to advance excellence in cannabis nursing practice through advocacy, collaboration, education, research, and policy development. http://americancannabisnursesassociation.org/
NOW, there's another Cannibus-Related Company within the Industrial Grade Hemp
CBD Oil Industry:
Well-anticipated by Experts to Reach that Same
Level of Exponential Growth!!!
This NEW and exciting company is called PrimeMyBody. This CBD Oil Company is offering a wonderful and prosperous opportunity in allowing you, the consumer, to also being a wonderful and growing family of shareholders to this growing company which is anticipated to reach the same exponential growth as its predecessors. Unlike its Cannibus CBD Oil counterpart, which is legal in only 16 states (as of 2/03/2017), Industrial-Grade Hemp CBD Oil is LEGAL in all 50 states!
PrimeMyBody is a health, wellness and lifestyle company that embraces the movement to raise awareness on the importance of living a clean and healthy lifestyle; what you put in and on your body matters. What we accept into our lives, both through our mind and body, has a direct impact on our overall wellness. Our goals is to join our Affiliates and customers on their wellness journey to help educate and empower them about better living, and how they can become an example for others to follow.
In the last 12 months, a Google search for “Cannabidiol” currently produces 1,500,000 results! This movement is being called the "Gold Standard in Health & Wellness," and PrimeMyBody is catching the Hemp Oil wave of demand! Learn how sharing our incredible plant-based products can reward you for sharing the love!
PrimeMyBody and its best-selling product (the CBD Oil extract) is a NEW and exciting company, which is starting at ground-level, combines nanoenhanced technology with a sustainable, naturally grown hemp oil, which has been used for a wide range of healthy benefits dating back more than 3,000 years. Our formula helps to optimize the mind & body, efficiently and naturally. Our NanoEnhanced "Industrial-Grade" Hemp CBD Oil is made with the highest quality hemp strains grown to strict organic standards that we can find. We use a super-critical whole plant extraction process that yields all of the synergistic cannabinoids, terpenoids and other natural compounds of the original plant. Our Hemp Oil is non-psychoactive and safe for daily consumption.
PrimeMyBody utilizes a unique liposomal delivery system, which dramatically improves the bioavailability of the oil. Our product is a Dietary Supplement and contains industrial hemp extract derived from the whole hemp plant, which delivers healthful benefits, without the psychoactive or “high" effect associated with this type of botanical.
10x bio-availability optimized hemp extract using exclusively natural, plant-based ingredients in a complete botanical formulation. The phospholipids that compose the liposome shell feed the cell membranes themselves. This promotes proper cellular function, like the absorption of the nutrients and the excretion of the cellular waste product and toxins.
PrimeMyBody provides up to 10 times more the absorption power that other CBD Oils. Most CBD Oils are wasted and expelled out through the digestive tract. Liposomal delivery brings the power of intravenous therapy into convenient oral delivery. Typical absorption of Cannabidiol oil is poor, with only about 10% uptake in the GI tract. Liposomal encapsulation of compounds similar to Cannabidiol have been shown to increase absorbtion five-to ten-fold. Our pharmaceutical-grade LIPOSOMAL Cannabidiol outperforms other products thanks to smaller, more stable, single-layer spheres made from the highest-grade ingredients available. Our liposomes bring the power of intravenous therapy into convenient oral delivery. Unlike other liposomes on the market that use low grades of phospholipids, which breakdown and do not deliver compounds effectively, the high-phosphatidylcholine phospholipid mixes are smaller, more stable, and tightly distributed single-layer spheres. Our vesicles are small enough to begin absorption as soon as they hit your mouth; it's lightning fast!
Phytocannabinoid Diols Uptake
In a test against Phytocannabinoid Diols uptake results published by a leading pharma brand, our liposomal hemp oil was absorbed in the blood in amounts three times as great at half the dose. In fact, phospholipid therapy in oral forms has a long and solid clinical history.
How Will Our High Quality Hemp Oil Work for You?
Hemp Extract compounds interact with our body’s naturally occurring cannabinoid receptors, addressing a range of traditional therapeutic uses. While we do not claim that our oil will cure, treat, or prevent any disease or illness, there is a great deal of pre-clinical research (including both cell culture and animal models) which demonstrate positive results for stomach or intestinal issues, overall well-being, mental clarity, rest, and the list goes on.
Once You've Tried Our CBD Oil, Spread the Word and Help to Heal Others!!! Tell your Friends & Family of What You Learned from this Presentation
AS PROMISED: THE "5" HIDDEN FACTS REVEALED
1. CBD Oil extracted from Industrial Hemp contains NO THC, which means No psychoactive side effects derived from THC-containg Cannibis. Additionally, this type of CBD Oil contains higher concentrations of Cannibidiol, which is the active ingredient or element which contributes to its healing effects. Furthermore, CBD Oil extracted from Hemp Seed contains, not only NO THC, but it also does not contain the higher effective concentrations of Cannibidiol. Be extremely wary about cheaper "Hemp Seed" CBD Oil products. Not only are you wasting your money, but (most importantly) you will not achieving the desired healing effects!!!
2. Unlike its THC-concentrated counterpart, "Industrial Hemp" extracted CBD Oil is LEGAL in all 50 states. CBD Oil extracted from THC-containing Cannibus is currently legal in only 16 states (As of: 1/23/2017)
3. The Truth about the Endocannabinoid System has been hidden from us in awareness. A fully functioning endocannabinoid system awakened from its dormancy within our bodies is crucial to overall health and healing. Endocannabinoids and their receptors are found throughout the body; in the brain, organs (pancreas and liver), connective tissue, bones, adipose tissues, nervous system, and immune system. We share this system in common with all other vertebrate animals, and some invertebrate animals (Sulak, 2015). Cannabinoids support homeostasis within the body’s system; the ECS is a central regulatory system, cannabinoid receptors are found throughout the body, and they are believed to be the largest receptor system in our bodies. Cell membrane cannabinoid receptors send information backwards, from the post-synaptic to the pre- synaptic nerve. CB1 (found primarily in the brain) and CB2 (mostly in the immune system and in the bones) are the main ECS receptors (Former, 2015), though several more are currently being studied. The exogenous phytocannabinoid THC, or the psychoactive compound in cannabis, works primarily on CB1 receptors (hence the “high feeling” in the brain), while the cannabinoid CBD works primarily with the immune system and creating homeostasis around the inflammatory response through CB2 receptors and does not have psychoactive effects. Other cannabinoids and their actions are still being studied, such as the non-psychoactive cannabinoids CBN and CBG, also found in cannabis. Our bodies react to both our own production of endogenous cannabinoids and to the ingestion of phyto-cannabinoids found in the cannabis plant, and other non-pyschoactive plants such as Echinacea.
4. Besides, many other health beneficial effects that "Industrial Hemp" CBD Oil possesses (in acting as a remedy for GERD, insomnia, seizures, anxiety, PTSD, neuropathic pain and ulcers) but it is also considered an anti-cancer agent and an inflammatory. Several thousand well-documented studies within the professional and scientific literature, points to the lucrative and miraculous effects to our overall health and well-being, and most importantly, it contributes to our own self-empowerment to continued Self-Healing!!!
5. Being a part of the growing and thriving CBD Oil is a No-Brainer. Be a part of this revolution. Almost all Cannabis-driven home-business start-up have reached exponential and unexpected highs's. A recent report by Forbes.com highlights the tremendous growth expceted in the cannabidiol (CBD) market over the next three years. The report also explains that hemp-derived CBD will account for $450 million of the estimated total sales of $2.1B by 2020. As quoted within this report, the cannabidiol (CBD) market is estimated to grow by 700% by 2020, according to Forbes. A new report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020, an astronomical jump in value compared to last year’s CBD market of $202 million.
Be an Affiliate Today: How will PrimeMyBody Work for Me?
This company offers individuals the opportunity to generate income by simply sharing our incredibly formulated plant-based products, and this Affiliate Program is set up to reward you for sharing the love! Watch the following video to better understand how this opportunity can work for you.
How Can I Make Money with PrimeMyBody!
This sketch presentation will walk you through the multiple ways you can be paid through our Rewards Plan! PrimeMyBody has the most creative Rewards Plan in the industry! Our Affiliates are able to generate income in 7 different ways, with the opportunity to receive company shares by climbing our prestigious ranks. We want our Affiliates to have long-term ownership, while working to build an incredibly large income.
Now, the Big Time Opportunity!!!
PrimeMyBody has the most creative Rewards Plan in the industry! Our Affiliates are able to generate income in 7 different ways, with the opportunity to receive company shares by climbing our prestigious ranks. We want our Affiliates to have long-term ownership, while working to build an incredibly large income.
How good does this feel?
Welcome to the World of "industrial Hemp" CBD Oil. Not only can we heal ourselves, which is so very important, BUT we can also heal others (the same) back to homeostasis!!!
Each "Nano-Enhanced" CBD Oil Bottle that you receive (in any package) can either be used for your own personalized healing in desired health and overall well-being or you can utilize them to help other potential affiliates (you invite) to try out the PrimeMyBody's CBD Oil samples for themselves. Essentially, the CBD Oil sells itself once more and more people begin to realize the Healing Nature of Industrial Hemp. In times of Self-Rediscovery, such as these when we can NOW reclaim our own Power to Self-Heal, we will also realize that such a movement is an Awakening of sorts - a Spiritual Awakening to Truth.
So, What Are You Waiting For?
We are always in constant pursuit of discovering the best version of ourselves and in sharing those discoveries with all who are on a similar path. We recognize how much effort and dedication must be applied to achieve success, that's why our team has put systems in place to help you build an ever-growing team. Come join our mission to live wellness, and create lifestyle!
Thank You for taking this time to view this vital & Life-Changing Information.
A person can become a PrimeMyBody Affiliate by purchasing the Business Center for $39.00 annually, which includes access to your personal business center, replicated website, and online marketing tools. No product purchase is required. Earnings or potential earnings of existing Independent Affiliates are not necessarily representative of the income a PrimeMyBody Affiliate can or will earn through their participation in PrimeMyBody. No one can be guaranteed success as a PrimeMyBody affiliate.